Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Weeks 13 and beyond: 8 to 12 mg once weekly (based on response and tolerance) This protocol reaches the therapeutic range in approximately 8 weeks
Moreover, case reports supporting BPC-157s use often come from individuals with potential conflicts of interest, which may compromise their reliability
A luciferase-fragment complementation assay to detect lipid droplet-associated proteinprotein interactions
Neovius M, Arkema EV, Olsson H, Eriksson JK, Kristensen LE, Simard JF, Askling J, Bcklund E, Cster L, Forsblad-d'Elia H, Feltelius N
The sulfasalazine-induced ferroptosis is partially eliminated by efficient ferroptosis inhibitors, supporting the rationale of applying ferroptosis to treat cancer in preclinical and clinical settings (Yin et al., 2023)